We could not find your search for PSSI Please try again.
Please check our suggestions as you type in the search box.
Bearish
Nov 08, 2012 | 8:21 AM EST
PSSI was downgraded to Neutral from Buy, UBS said. $29 price target. 10Q reveals inline results. 
Bullish
May 21, 2012 | 8:23 AM EDT
PSSI was initiated with a Buy rating, UBS said.  $26 price target.  Market has overcorrected the stock price. 
Bearish
May 11, 2012 | 6:43 AM EDT
PSSI was downgraded from Outperform to Neutral, Robert Baird said. $21 price target. Company missed expectations again and lacks near-t...
Medical equipment makers and suppliers could be just the right remedy.

Columnist Conversations

Khan:
This stock is trending on YHOO and jumping... In the dot-com bubble era the worry was no profit. Now no profit...
Keep an eye on Wayfair, which recently filed for its IPO. Killing it on pricing in home goods head/head with W...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
HLF is trading $51.05, up 3.2% with IV30™ ripping up 21.5%. The Symbol Summary is included below. Concl...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.